CDSCO approves antibody cocktail drug for restricted emergency use to treat mild Covid-19 cases
CDSCO approves use of antibodies cocktail drug (Casirivimab and Imdevimab) for restricted emergency use to treat mild to moderate Covid-19 in adults and paediatric patients.
advertisement
Health workers inspect Covid-19 patients at a hospital in New Delhi. (Photo credit: PTI).
The Indian regulatory body, Central Drugs Standards Control Organisation (CDSCO), has approved the use of antibodies cocktail drug (Casirivimab and Imdevimab), for restricted emergency used to treat mild to moderate Covid-19 in adults and paediatric patients (12 years or weighing more than at least 40 kg).
Antibodies Cocktail Drug can be a game-changer in Covid-19 treatment, especially when these are recommended to be given at the early stages of laboratory-confirmed SARS-CoV-2 infection positive result. Theis is preferebly administered within 10 days of symptoms onset.
URL copied
No proof of Remdesivir s effectiveness in COVID patients
Ganga Ram hospital Chairperson Dr. DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. This move comes after, the use of convalescent plasma has been dropped from the recommended treatment protocols for COVID -19, according to an advisory from the Indian Council of Medical Research (ICMR).
Ganga Ram hospital Chairperson Dr. DS Rana further said, In plasma therapy, we give a pre-forwarded antibody to someone who has been infected before, so that the antibody can fight with the virus. Antibodies usually form when the coronavirus attacks. We have seen in the last year that giving plasma does not make any difference in the condition of the patient and other people. Also, it is not easily available. Plasma therapy was started on a scientific basis and has been discontinued on th
This emergency use authorisation (EUA) will now enable Roche to import the globally manufactured product batches to India and will be marketed as well as distributed in India through a strategic partnership with Cipla Limited.
Viral: Families of COVID-19 patients touch feet of CMO begging for Remdesivir
Many others could also be seen weeping, touching the feet of the Chief Medical Officer, and begging him to get Remdesivir for their patient. (Image Source: Reuters)
Updated: Apr 28, 2021, 04:25 PM IST
The condition in India due to the second wave of the COVID-19 pandemic is so grave that it can be understood by a viral video that has left netizens to tears. Shared by news agency ANI, the video shows families of COVID-19 patients in Uttar Pradesh s Noida, touching the feet of Chief Medical officer Deepak Ohri, requesting him that they be provided with anti-viral drug Remdesivir.